Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) Q2 2021 Results Conference Call August 5, 2021 8:00 AM ET Company Participants Joshua Reed - Chief Financial Officer Todd Brady - President & Chief Executive Officer Conference Call Participants Marc Goodman - SVB Leerink Edwin Zhang - H.C. Wainwright Esther Hong - Berenberg Prakhar Agrawal - JonesTrading Matt Cross - Alliance Global Tom Shrader - BTIG Yigal Nochomovitz - Citigroup Operator Ladies and gentlemen, thank you for standing by, and welcome to the Aldeyra T ...

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) Q1 2021 Earnings Conference Call May 6, 2021 8:00 AM ET Company Participants Joshua Reed - Chief Financial Officer Todd Brady - President & Chief Executive Officer Conference Call Participants Justin Kim - Oppenheimer Kelly Shi - Jefferies Marc Goodman - SVB Leerink Edwin Zhang - H.C. Wainwright Esther Hong - Berenberg Prakhar Agrawal - JonesTrading Yale Jen - Laidlaw & Company Operator Ladies and gentlemen, thank you for standing by and welcome to the Aldeyra Therap ...

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) Q4 2020 Earnings Conference Call March 11, 2021 8:00 AM ET Company Participants Joshua Reed - Chief Financial Officer Todd Brady - President & Chief Executive Officer Conference Call Participants Yigal Nochomovitz - Citigroup Louise Chen - Cantor Fitzgerald Kelly Shi - Jefferies Justin Kim - Oppenheimer Matthew Cross - Alliance Global Partners Julian Harrison - BTIG Esther Hong - Berenberg Edwin Zhang - H.C. Wainwright Prakhar Agrawal - JonesTrading Yale Jen - Laidla ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36332 ALDEYRA THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) Delaware 20-1968197 (State or othe ...

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) Q3 2020 Results Earnings Conference Call November 5, 2020 8:00 AM ET Company Participants Joshua Reed - Chief Financial Officer Todd Brady - President & Chief Executive Officer David McMullin - Chief Business Officer Conference Call Participants Samantha Semenkow - Citi Jennifer Kim - Cantor Fitzgerald Jackie Yan - Oppenheimer Matt Cross - Alliance Global Partners Julian Harrison - BTIG Kelly Shi - Jefferies Operator Good morning and welcome to the Aldeyra Therapeuti ...

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) Q2 2020 Earnings Conference Call August 6, 2020 8:00 AM ET Company Participants Joshua Reed - CFO Todd Brady - CEO, President & Director Conference Call Participants Louise Chen - Cantor Fitzgerald & Co. Justin Kim - Oppenheimer Operator Ladies and gentlemen, thank you for standing by, and welcome to the Aldeyra Therapeutics Second Quarter 2020 Financial Results Conference Call. [Operator Instructions]. I would now like to introduce the company's Chief Financial Offi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36332 ALDEYRA THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) Delaware 20-1968197 (State or other jur ...